DTx Pharma

About:

DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.

Website: http://dtxpharma.com

Twitter/X: DTxPharma

Top Investors: RA Capital Management, Eli Lilly, Cormorant Asset Management, Grant Van Cleve, Janus Henderson Investors

Description:

DTx Pharma develops technology that will unleash RNA-based therapeutics as the modality of choice for personalized treatment across therapeutic areas. DTx Pharma believes its approach to delivering RNA medicines solves some of the issues that limited previous-generation platforms, including poor pharmacokinetics and insufficient cellular uptake.